ClinVar Miner

Submissions for variant NM_000329.3(RPE65):c.130C>T (p.Arg44Ter) (rs368088025)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Praxis fuer Humangenetik Tuebingen RCV000416243 SCV000493266 likely pathogenic not provided 2016-08-01 criteria provided, single submitter clinical testing
Invitae RCV000528380 SCV000644181 pathogenic Leber congenital amaurosis 2; Retinitis pigmentosa 20 2017-11-18 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal at codon 44 (p.Arg44*) of the RPE65 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPE65 are known to be pathogenic. This particular variant has been reported in the literature in individuals affected with Leber congenital amaurosis (PMID: 26626312). For these reasons, this variant has been classified as Pathogenic.
Medical Genetics Laboratory, Kennedy Center,Juliane Marie Center, Rigshospitalet RCV000787883 SCV000926899 likely pathogenic Retinitis pigmentosa 2018-04-01 no assertion criteria provided research
GenomeConnect, ClinGen RCV001249416 SCV001423417 not provided RPE65-Related Disorders no assertion provided phenotyping only Variant interpretted as Pathogenic and reported on 02-05-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.